FDA Grants Priority Review to Lymphoseek Sentinel Lymph Node Application
FDA has accepted a supplemental new drug application from Navidea Biopharmaceuticals, granting priority review for the expanded use of injection with Lymphoseek, as indicated for sentinel lymph node detection in patients with head and neck cancer.
Read More